These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34179969)

  • 1. Neuraminidase 1 is a driver of experimental cardiac hypertrophy.
    Chen QQ; Ma G; Liu JF; Cai YY; Zhang JY; Wei TT; Pan A; Jiang S; Xiao Y; Xiao P; Song J; Li P; Zhang L; Qi LW
    Eur Heart J; 2021 Sep; 42(36):3770-3782. PubMed ID: 34179969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages.
    Heimerl M; Sieve I; Ricke-Hoch M; Erschow S; Battmer K; Scherr M; Hilfiker-Kleiner D
    Basic Res Cardiol; 2020 Sep; 115(6):62. PubMed ID: 32975669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuraminidase 1 Exacerbating Aortic Dissection by Governing a Pro-Inflammatory Program in Macrophages.
    Wang Q; Chen Z; Peng X; Zheng Z; Le A; Guo J; Ma L; Shi H; Yao K; Zhang S; Zheng Z; Zhu J
    Front Cardiovasc Med; 2021; 8():788645. PubMed ID: 34869700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meox1 accelerates myocardial hypertrophic decompensation through Gata4.
    Lu D; Wang J; Li J; Guan F; Zhang X; Dong W; Liu N; Gao S; Zhang L
    Cardiovasc Res; 2018 Feb; 114(2):300-311. PubMed ID: 29155983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase 1 promotes renal fibrosis development in male mice.
    Chen QQ; Liu K; Shi N; Ma G; Wang P; Xie HM; Jin SJ; Wei TT; Yu XY; Wang Y; Zhang JY; Li P; Qi LW; Zhang L
    Nat Commun; 2023 Mar; 14(1):1713. PubMed ID: 36973294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA
    Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G
    Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.
    Wei X; Wu B; Zhao J; Zeng Z; Xuan W; Cao S; Huang X; Asakura M; Xu D; Bin J; Kitakaze M; Liao Y
    Circulation; 2015 Apr; 131(17):1506-17; discussion 1517. PubMed ID: 25820336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy.
    Li PL; Liu H; Chen GP; Li L; Shi HJ; Nie HY; Liu Z; Hu YF; Yang J; Zhang P; Zhang XJ; She ZG; Li H; Huang Z; Zhu L
    Hypertension; 2020 Oct; 76(4):1219-1230. PubMed ID: 32862709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
    Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
    Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEU1 Regulates Mitochondrial Energy Metabolism and Oxidative Stress Post-myocardial Infarction in Mice
    Guo Z; Fan D; Liu FY; Ma SQ; An P; Yang D; Wang MY; Yang Z; Tang QZ
    Front Cardiovasc Med; 2022; 9():821317. PubMed ID: 35548408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase 1 deficiency attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory via AMPK-SIRT3 pathway in diabetic cardiomyopathy mice.
    Guo Z; Tuo H; Tang N; Liu FY; Ma SQ; An P; Yang D; Wang MY; Fan D; Yang Z; Tang QZ
    Int J Biol Sci; 2022; 18(2):826-840. PubMed ID: 35002528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy.
    Viereck J; Bührke A; Foinquinos A; Chatterjee S; Kleeberger JA; Xiao K; Janssen-Peters H; Batkai S; Ramanujam D; Kraft T; Cebotari S; Gueler F; Beyer AM; Schmitz J; Bräsen JH; Schmitto JD; Gyöngyösi M; Löser A; Hirt MN; Eschenhagen T; Engelhardt S; Bär C; Thum T
    Eur Heart J; 2020 Sep; 41(36):3462-3474. PubMed ID: 32657324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HINT1 (Histidine Triad Nucleotide-Binding Protein 1) Attenuates Cardiac Hypertrophy Via Suppressing HOXA5 (Homeobox A5) Expression.
    Zhang Y; Da Q; Cao S; Yan K; Shi Z; Miao Q; Li C; Hu L; Sun S; Wu W; Wu L; Chen F; Wang L; Gao Y; Huang Z; Shao Y; Chen H; Wei Y; Chen F; Han Y; Xie L; Ji Y
    Circulation; 2021 Aug; 144(8):638-654. PubMed ID: 34098726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4.
    Kwon DH; Eom GH; Kee HJ; Nam YS; Cho YK; Kim DK; Koo JY; Kim HS; Nam KI; Kim KK; Lee IK; Park SB; Choi HS; Kook H
    J Mol Cell Cardiol; 2013 Dec; 65():88-97. PubMed ID: 24083978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Effect of Neuraminidase-1-Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis.
    Luzina IG; Lillehoj EP; Lockatell V; Hyun SW; Lugkey KN; Imamura A; Ishida H; Cairo CW; Atamas SP; Goldblum SE
    J Pharmacol Exp Ther; 2021 Jan; 376(1):136-146. PubMed ID: 33139318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuraminidase 1 and its Inhibitors from Chinese Herbal Medicines: An Emerging Role for Cardiovascular Diseases.
    Zhang JY; Chen QQ; Li J; Zhang L; Qi LW
    Am J Chin Med; 2021; 49(4):843-862. PubMed ID: 33827385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.
    Mehta G; Kumarasamy S; Wu J; Walsh A; Liu L; Williams K; Joe B; de la Serna IL
    J Mol Cell Cardiol; 2015 Nov; 88():101-10. PubMed ID: 26388265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3.
    Guo R; Liu N; Liu H; Zhang J; Zhang H; Wang Y; Baruscotti M; Zhao L; Wang Y
    Phytomedicine; 2020 Mar; 68():153171. PubMed ID: 32018211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.